Investors Menu
Investors Tools
BBOT’s legal name is [TheRas, Inc. d/b/a] BridgeBio Oncology Therapeutics.
BBOT’s corporate headquarters is located at: 256 E. Grand Avenue, Suite 104, South San Francisco, CA 94080
BBOT is incorporated in the state of Delaware.
The business combination between BBOT and Helix Acquisition Corp. II closed on August 11.
BBOT’s fiscal year end is December 31.
BBOT is traded on the Nasdaq Global Market under the ticker symbol “BBOT”, and the ISIN Number is US1079241022.
Shares of BBOT’s stock can be purchased by contacting a securities broker of your choice.
BBOT intends to retain all available funds and any future earnings for use in the operation of its business and does not anticipate paying any cash dividends on its capital stock in the foreseeable future.
BBOT’s transfer agent is: Continental Stock Transfer & Trust Company, 1 State Street 30th Floor, New York, New York 10004, Tel: (212) 509-4000.
For these matters, please contact BBOT’s transfer agent: Continental Stock Transfer & Trust Company, 1 State Street 30th Floor, New York, New York 10004, Tel: (212) 509-4000.
BBOT’s independent auditors are Deloitte & Touche LLP.
BBOT’s legal counsel is Goodwin Procter LLP.
Please visit BBOT’s website at: bbotx.com.
BBOT’s news releases can be viewed here.
BBOT’s SEC filings can be viewed here.
BBOT’s Leadership Team and Board of Directors can be viewed here.
Please submit queries by contacting contact@bbotx.com.
You can sign up to receive email alerts here.